PUNE, India, February 12, 2016 /PRNewswire/ --
According to a new market research report "HPV Testing & Pap Test Market by Test Type (HPV Testing (Follow-Up, Co-Testing, Primary)), by Application (Pap Test (Cervical Cancer, Vaginal Cancer)), by End User (Laboratories, Hospitals, Physicians' Offices & Clinics) - Global Forecast to 2020", published by MarketsandMarkets, the global market is poised to reach USD 4,523.1 Million by 2020 from USD 3,287.4 Million in 2015, at a CAGR of 6.6% from 2015 to 2020.
Browse 80 market data Tables and 52 Figures spread through 124 Pages and in-depth TOC on "HPV Testing & Pap Test Market"
Early buyers will receive 10% customization on this report.
A number of factors such as increasing number of cervical cancer cases, growing aging population, increasing awareness of cervical cancer screening programs, and government initiative and funding are propelling the growth of the HPV Testing and Pap Test Market. However, changes in regulatory guidelines for cervical cancer screening and HPV vaccination are some major factors restraining the growth of this market. In addition to this, the uncertain reimbursement scenario serves to be a major challenge impacting the growth of the HPV test and Pap test market.
HPV Testing and Pap Test Market has been divided into two major segments on basis of test type, namely, HPV testing and Pap test. Follow-up HPV testing, co-testing, HPV primary testing are three sub-segments of HPV testing. The Pap test segment is expected to account for the largest share of the HPV Testing and Pap Test Market in 2015. HPV testing segment is expected to grow at the highest CAGR in the next five years. This fastest growth is attributed to the increasing incidences of cervical cancer, raising awareness of HPV screening, as well as the introduction of HPV primary test.
Inquiry before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=214207371
On the basis of type of application, the global HPV Testing and Pap Test Market is classified into two major segments, namely, cervical cancer screening and vaginal cancer screening. The cervical cancer screening application segment is expected account for the largest share of the Pap test market in 2015. This large share can be attributed to the increasing incidences of cervical cancer and government initiatives to spread the awareness about cervical cancer screening.
HPV Testing and Pap Test Market is classified into three segments on the basis of end users, namely, hospitals, laboratories, physicians' offices and clinics. The laboratories end-user segment is expected account for the largest share of the HPV Testing and Pap Test Market in 2015. Furthermore, the hospitals end-user segment is expected to grow at the highest CAGR in the next five years, as most of the diagnostic tests are carried out in-house in hospitals with advanced technologies in shorter period of time.
Abbott Laboratories (U.S.), Qiagen N.V. (The Netherlands), Hologic Inc. (U.S.), Roche Diagnostics (Switzerland), Quest Diagnostics (U.S.), Becton, Dickinson and Company (U.S.) are the key players operating in the HPV Testing and Pap Test Market.
Browse Related Reports:
Molecular Diagnostics Market by Application (Infectious Disease (HIV, HPV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Microarray, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Software) - Forecast to 2020.
Infectious Disease Diagnostics Market by Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospital, Laboratories) - Global Forecast to 2019.
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune - 411013,
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets